Imaging the metabolic footprint of Glut1 deficiency on the brain
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Cerebral 18 F‐fluorodeoxyglucose positron emission tomography in 14 patients with microcephaly, developmental delay, seizures, and mutations of the glucose transporter Glut1 (Glut1 deficiency syndrome) showed distinct abnormalities. Within a global context of diminished cortical uptake, more severe hypometabolism was found in the mesial temporal regions and thalami, accentuating a relative signal increase in the basal ganglia. In contrast, the structure of the brain appeared preserved in patients additionally investigated by magnetic resonance imaging. This metabolic footprint was relatively constant in all patients regardless of age, seizure history, or therapies and therefore constitutes a radiological signature of the disease. The full expression of the signature in the youngest patient (aged 19 months) indicates that the state of haploinsufficiency caused by Glut1 mutation leaves a permanent footprint on the nervous system from its earlier postnatal stages of development. The potential benefit of prompt diagnosis, aided by 18 F‐fluorodeoxyglucose positron emission tomography, and early initiation of available therapies is underscored by our results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Brain stem reticular formation and activation of the EEG
Moruzzi, G., & Magoun, H. W. (1949) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(49)90219-9 · Cited by 4,307
Positron emission tomography study of human brain functional development
Chugani, H. T., Phelps, M. E., & Mazziotta, J. C. (1987) · Annals of Neurology · doi:10.1002/ana.410220408 · Cited by 1,548
Changeux, J.-P., & Danchin, A. (1976) · Nature · doi:10.1038/264705a0 · Cited by 1,448
The thalamic matrix and thalamocortical synchrony
Jones, E. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01922-6 · Cited by 688
Chugani, H. T., & Phelps, M. E. (1986) · Science · doi:10.1126/science.3945811 · Cited by 663 · cited 2×
“Among the first structures to display metabolic activity by FDG-PET in the newborn are the thalamus, the sensory and motor cortices, the cerebellar vermis, and the brainstem.(1) Our results are compatible with an early (perhaps prenatal) effect of the disease on the structures that first start to mature, that is, the…”
BackgroundResultOver-expression of facilitative glucose transporter genes in human cancer
Yamamoto, T., Seino, Y., Fukumoto, H., Koh, G., Yano, H., Inagaki, N., Yamada, Y., Inoue, K., Manabe, T., & Imura, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91263-r · Cited by 465
Wender, R., Brown, A. M., Fern, R., Swanson, R. A., Farrell, K., & Ransom, B. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06804.2000 · Cited by 374
Do active cerebral neurons really use lactate rather than glucose?
Chih, C.-P., Lipton, P., & Roberts, E. L. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01920-2 · Cited by 252
Cited by
Crystal structure of the human glucose transporter GLUT1
Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N. (2014) · Nature · doi:10.1038/nature13306 · Cited by 777
Glucose transporters in brain in health and disease
Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558
“Downregulation of GLUT1-mediated D-glucose uptake into brain can be detected by PET using [(18)F]DOG [2, 318].”
BackgroundGlucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 361
Imaging of the Dynamics of Glucose Uptake in the Cytosol of COS-7 Cells by Fluorescent Nanosensors
Fehr, M., Lalonde, S., Lager, I., Wolff, M. W., & Frommer, W. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301333200 · Cited by 295
Klepper, J., Akman, C., Armeno, M., Auvin, S., Cervenka, M., Cross, H. J., De Giorgis, V., Della Marina, A., Engelstad, K., Heussinger, N., et al. (2020) · Epilepsia Open · doi:10.1002/epi4.12414 · Cited by 285
Self-citationPhenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Pearson, T. S., Akman, C., Hinton, V. J., Engelstad, K., & De Vivo, D. C. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0342-7 · Cited by 227
“The first clinical report describing fluorodeoxyglucose positron emission tomography (FDG-PET) imaging findings in Glut1 DS demonstrated widespread hypometabolism in neocortical regions and marked hypometabolism in the thalamus [22], suggesting impaired function of thalamo-cortical networks as a possible factor in epi…”
BackgroundSelf-citationGlucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy
Mullen, S. A., Marini, C., Suls, A., Mei, D., Della Giustina, E., Buti, D., Arsov, T., Damiano, J., Lawrence, K., De Jonghe, P., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.102 · Cited by 138
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Faculty, O. B. O. T. M., Boche, D., Gerhard, A., & Rodriguez-Vieitez, E. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04462-w · Cited by 55
Metadata
- Authors
- Pascual, J. M., van Heertum, R. L., Wang, D., Engelstad, K., & De Vivo, D. C.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2002-08-25
- Volume
- 52
- Issue
- 4
- Pages
- 458-464
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2058807553
- Cited by
- 155
- References
- 9
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.